Skip to main navigation Skip to search Skip to main content

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

  • Nichola Johnson
  • , Sarah Maguire
  • , Anna Morra
  • , Pooja Middha Kapoor
  • , Katarzyna Tomczyk
  • , Michael E. Jones
  • , Minouk J. Schoemaker
  • , Clare Gilham
  • , Manjeet K. Bolla
  • , Qin Wang
  • , Joe Dennis
  • , Thomas U. Ahearn
  • , Irene L. Andrulis
  • , Hoda Anton-culver
  • , Natalia N. Antonenkova
  • , Volker Arndt
  • , Kristan J. Aronson
  • , Annelie Augustinsson
  • , Caroline Baynes
  • , Laura E. Beane Freeman
  • Matthias W. Beckmann, Javier Benitez, Marina Bermisheva, Carl Blomqvist, Bram Boeckx, Natalia V. Bogdanova, Stig E. Bojesen, Hiltrud Brauch, Hermann Brenner, Barbara Burwinkel, Daniele Campa, Federico Canzian, Jose E. Castelao, Stephen J. Chanock, Georgia Chenevix-trench, Christine L. Clarke, Don M. Conroy, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Thilo Dörk, A. Heather Eliassen, Christoph Engel, D. Gareth Evans, Peter A. Fasching, Jonine Figueroa, Giuseppe Floris, Henrik Flyger, Manuela Gago-dominguez, Susan M. Gapstur, Montserrat García-closas, Mia M. Gaudet, Graham G. Giles, Mark S. Goldberg, Anna González-neira, Pascal Guénel, Eric Hahnen, Christopher A. Haiman, Niclas Håkansson, Per Hall, Ute Hamann, Patricia A. Harrington, Steven N. Hart, Maartje J. Hooning, John L. Hopper, Anthony Howell, David J. Hunter, Agnes Jager, Anna Jakubowska, Esther M. John, Rudolf Kaaks, Renske Keeman, Elza Khusnutdinova, Cari M. Kitahara, Veli-matti Kosma, Stella Koutros, Peter Kraft, Vessela N. Kristensen, Allison W. Kurian, Diether Lambrechts, Loic Le Marchand, Martha Linet, Jan Lubiński, Arto Mannermaa, Siranoush Manoukian, Sara Margolin, John W. M. Martens, Dimitrios Mavroudis, Rebecca Mayes, Alfons Meindl, Roger L. Milne, Susan L. Neuhausen, Heli Nevanlinna, William G. Newman, Sune F. Nielsen, Børge G. Nordestgaard, Nadia Obi, Andrew F. Olshan, Janet E. Olson, Håkan Olsson, Ester Orban, Tjoung-won Park-simon, Paolo Peterlongo, Dijana Plaseska-karanfilska, Katri Pylkäs, Gad Rennert, Hedy S. Rennert, Kathryn J. Ruddy, Emmanouil Saloustros, Dale P. Sandler, Elinor J. Sawyer, Rita K. Schmutzler, Christopher Scott, Xiao-ou Shu, Jacques Simard, Snezhana Smichkoska, Christof Sohn, Melissa C. Southey, John J. Spinelli, Jennifer Stone, Rulla M. Tamimi, Jack A. Taylor, Rob A. E. M. Tollenaar, Ian Tomlinson, Melissa A. Troester, Thérèse Truong, Celine M. Vachon, Elke M. Van Veen, Sophia S. Wang, Clarice R. Weinberg, Camilla Wendt, Hans Wildiers, Robert Winqvist, Alicja Wolk, Wei Zheng, Argyrios Ziogas, Alison M. Dunning, Paul D. P. Pharoah, Douglas F. Easton, A. Forbes Howie, Julian Peto, Isabel Dos-santos-silva, Anthony J. Swerdlow, Jenny Chang-claude, Marjanka K. Schmidt, Nick Orr, Olivia Fletcher

Research output: Contribution to journalArticlepeer-review

Abstract

Background
Epidemiological studies provide strong evidence for a role of endogenous sex hormones in the aetiology of breast cancer. The aim of this analysis was to identify genetic variants that are associated with urinary sex-hormone levels and breast cancer risk.

Methods
We carried out a genome-wide association study of urinary oestrone-3-glucuronide and pregnanediol-3-glucuronide levels in 560 premenopausal women, with additional analysis of progesterone levels in 298 premenopausal women. To test for the association with breast cancer risk, we carried out follow-up genotyping in 90,916 cases and 89,893 controls from the Breast Cancer Association Consortium. All women were of European ancestry.

Results
For pregnanediol-3-glucuronide, there were no genome-wide significant associations; for oestrone-3-glucuronide, we identified a single peak mapping to the CYP3A locus, annotated by rs45446698. The minor rs45446698-C allele was associated with lower oestrone-3-glucuronide (−49.2%, 95% CI −56.1% to −41.1%, P = 3.1 × 10–18); in follow-up analyses, rs45446698-C was also associated with lower progesterone (−26.7%, 95% CI −39.4% to −11.6%, P = 0.001) and reduced risk of oestrogen and progesterone receptor-positive breast cancer (OR = 0.86, 95% CI 0.82–0.91, P = 6.9 × 10–8).

Conclusions
The CYP3A7*1C allele is associated with reduced risk of hormone receptor-positive breast cancer possibly mediated via an effect on the metabolism of endogenous sex hormones in premenopausal women.
Original languageEnglish
JournalBritish Journal of Cancer
Early online date26 Jan 2021
DOIs
Publication statusPublished - 26 Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers'. Together they form a unique fingerprint.

Cite this